---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-043538"
form_type: "8-K"
ticker: "EW"
cik: "0001099800"
company_name: "Edwards Lifesciences Corp"
filed_at: "2023-02-21T23:59:59+00:00"
generated_at: "2026-06-19T06:25:09.066407+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Edwards Lifesciences amends bylaws to adopt universal proxy rules and update advance notice provisions

## Summary
- Bylaws amended to incorporate Rule 14a-19 universal proxy requirements for director nominations.
- Stockholders must provide evidence of compliance with universal proxy rules, including soliciting at least 67% voting power.
- Advance notice provisions updated with additional disclosure requirements for nominees and proposing stockholders.
- Company may require proposed nominees to submit to interviews with the Board or a committee.
- Other technical and conforming changes to align with recent amendments to Delaware General Corporation Law.

## SEC filing metadata
- accession: 0001193125-23-043538
- form_type: 8-K
- ticker: EW
- cik: 0001099800
- company_name: Edwards Lifesciences Corp
- filed_at: 2023-02-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1099800/000119312523043538/0001193125-23-043538-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1099800/000119312523043538/d452156d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-043538
- JSON: https://secwatch.observer/filing/0001193125-23-043538.json
- Plain text: https://secwatch.observer/filing/0001193125-23-043538.txt

## Key facts
- Governance Changes
  Edwards Lifesciences Corp: Amended and restated Bylaws to incorporate universal proxy rule (Rule 14a-19) and update advance notice provisions for director nominations, including new disclosure and compliance requirements (effective 2023-02-16).
  - Change: bylaw amendment
  - Effective: 2023-02-16
  source text: On February 16, 2023, the Board of Directors (the “Board”) of Edwards Lifesciences Corporation, a Delaware corporation (the “Company”), amended and restated the Company’s Bylaws (as so amended and restated, the “Bylaws”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1099800/000119312523043538/0001193125-23-043538-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.